PROM1 and head and neck squamous cell carcinoma: Compared with CD133− HNSCC cells, CD133+ CSC-like cells are more resistant to CDDP treatment, while we found that C2 effectively inhibited the growth of both CD133+ and CD133− HNSCC cells.